Search Results - "Fujimoto, Mutsumi"
-
1
A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
Published in Surgical case reports (01-12-2023)“…Background CA15-3 is often elevated in breast cancer recurrence and rarely in ductal carcinoma in situ (DCIS). We report a case of DCIS with elevated CA15-3…”
Get full text
Journal Article -
2
Laparoscopic repair of sciatic hernia recognizing the ureterohypogastric nerve fascia and vesicohypogastric fascia: a case report
Published in Surgical case reports (11-01-2022)“…Background Sciatic hernias are rare pelvic floor hernias that occur through the sciatic foramen and often present as abdominal or pelvic pain, particularly in…”
Get full text
Journal Article -
3
A Case of Breast Metastasis from Renal Cell Carcinoma
Published in Gan to kagaku ryoho (01-12-2022)“…The patient was a woman in her 90s. Right radical nephrectomy for right renal cell carcinoma had been performed 2 years and 6 months ago. Since then, there had…”
Get more information
Journal Article -
4
Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy
Published in Journal of magnetic resonance imaging (29-05-2024)“…Peritumoral edema (PE) identified on T2-weighted breast MRI is a factor for poor prognosis in breast cancer. To assess the prognostic value of residual PE…”
Get full text
Journal Article -
5
PO144 ORAL HYGIENE PARAMETERS FOR FEBRILE NEUTROPENIA DURING BREAST CANCER CHEMOTHERAPY
Published in Breast (Edinburgh) (01-10-2023)Get full text
Journal Article -
6
A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score
Published in Japanese journal of clinical oncology (04-09-2024)“…Abstract Background The tumor-infiltrating lymphocytes-ultrasonography score is a calculation system for predicting lymphocyte-predominant breast cancers in…”
Get full text
Journal Article -
7
Abstract P4-09-11: Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Background CDK4/6 inhibitors are the latest and highly specific CDK inhibitors approved for metastatic and early estrogen receptor (ER)-positive breast cancer…”
Get full text
Journal Article -
8
Abstract PO3-07-12: Effect of neoadjuvant chemotherapy on peritumoral edema in early stage breast cancer and its prognostic value
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Objectives: We aimed to evaluate the effect of neoadjuvant chemotherapy (NAC) on peritumoral edema (PE) and its prognostic value in operable breast cancer…”
Get full text
Journal Article -
9
Diagnostic performance of TILs-US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer
Published in International journal of clinical oncology (03-10-2024)“…Tumor-infiltrating lymphocytes-ultrasonography (TILs-US) score is used to predict lymphocyte-predominant breast cancer (LPBC) in surgical specimens. We aimed…”
Get full text
Journal Article